214 related articles for article (PubMed ID: 31176590)
1. A Comparison of Cryoablation with Heat-Based Thermal Ablation for Treatment of Clinical T1a Renal Cell Carcinoma: A National Cancer Database Study.
Wu J; Chang J; Bai HX; Su C; Zhang PJ; Karakousis G; Reddy S; Hunt S; Soulen MC; Stavropoulos SW; Zhang Z
J Vasc Interv Radiol; 2019 Jul; 30(7):1027-1033.e3. PubMed ID: 31176590
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation.
Uhlig A; Uhlig J; Trojan L; Kim HS
J Vasc Interv Radiol; 2020 Apr; 31(4):564-571. PubMed ID: 32127324
[TBL] [Abstract][Full Text] [Related]
3. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
5. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
[TBL] [Abstract][Full Text] [Related]
7. Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell Carcinoma.
Sorce G; Hoeh B; Hohenhorst L; Panunzio A; Tappero S; Tian Z; Kokorovic A; Larcher A; Capitanio U; Tilki D; Terrone C; Chun FKH; Antonelli A; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
J Urol; 2023 Jan; 209(1):81-88. PubMed ID: 36440817
[TBL] [Abstract][Full Text] [Related]
8. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
Zhou W; Arellano RS
J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
[TBL] [Abstract][Full Text] [Related]
9. Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma.
Palumbo C; Cyr SJ; Mazzone E; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Kapoor A; Antonelli A; Karakiewicz PI
J Endourol; 2019 Jul; 33(7):606-613. PubMed ID: 30990074
[No Abstract] [Full Text] [Related]
10. Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes.
Haddad MM; Schmit GD; Kurup AN; Schmitz JJ; Boorjian SA; Geske J; Thompson RH; Callstrom MR; Atwell TD
J Vasc Interv Radiol; 2018 Aug; 29(8):1122-1126. PubMed ID: 29887184
[TBL] [Abstract][Full Text] [Related]
11. Partial nephrectomy vs cryoablation for T1a renal cell carcinoma: A comparison of survival benefit stratified by tumour size.
Liao X; Qiu S; Wang W; Zheng X; Jin K; Zhang S; Bao Y; Yang L; Wei Q
Cancer Epidemiol; 2019 Apr; 59():221-226. PubMed ID: 30836219
[TBL] [Abstract][Full Text] [Related]
12. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
[TBL] [Abstract][Full Text] [Related]
14. Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma.
Dreyfuss LD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Nakada SY; Abel EJ
Urology; 2019 Dec; 134():148-153. PubMed ID: 31465794
[TBL] [Abstract][Full Text] [Related]
15. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
[TBL] [Abstract][Full Text] [Related]
16. Local ablation vs partial nephrectomy in T1N0M0 renal cell carcinoma: An inverse probability of treatment weighting analysis.
Shi L; He Y; Liu C; Qian X; Wang Z
Cancer Med; 2020 Nov; 9(21):7988-8003. PubMed ID: 32888392
[TBL] [Abstract][Full Text] [Related]
17. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous CT- and MRI-guided Cryoablation of cT1 Renal Cell Carcinoma: Intermediate- to Long-term Outcomes in 307 Patients.
Bhagavatula SK; Tuncali K; Shyn PB; Levesque VM; Chang SL; Silverman SG
Radiology; 2020 Sep; 296(3):687-695. PubMed ID: 32633677
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous Microwave Ablation versus Laparoscopic Partial Nephrectomy for cT1a Renal Cell Carcinoma: A Propensity-matched Cohort Study of 1955 Patients.
Yu J; Zhang X; Liu H; Zhang R; Yu X; Cheng Z; Han Z; Liu F; Hao G; Mu MJ; Liang P
Radiology; 2020 Mar; 294(3):698-706. PubMed ID: 31961239
[TBL] [Abstract][Full Text] [Related]
20. Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation.
Chen JX; Maass D; Guzzo TJ; Bruce Malkowicz S; Wein AJ; Soulen MC; Clark TWI; Nadolski GJ; William Stavropoulos S
J Vasc Interv Radiol; 2016 Sep; 27(9):1397-1406. PubMed ID: 27234485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
